priority meds semaglutide The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Tirzepatide vs. Semaglutide for Weight

A Cornell University study published in the Journal of Marketing Research found that GLP-1 users reduced household grocery spending by an average of 5.3% within six months of starting treatment, with spending on savory snacks falling approximately 10% and similar declines in sweets, baked goods, and cookies

Omega-3 and6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: a randomized controlled trial

CrossRef Direct-acting Antivirals Therapy for Hepatocellular Carcinoma in Hepatitis C Patients Seul Ki Han, Soon Koo Baik, Moon Young Kim Journal of Digestive Cancer Research .2025

In mice, the knock-out of the GIPR gene is correlated with reductions in hepatic lipid content

Anecdotal reports show that women in midlife are losing weight on GLP-1 medications, and stubborn weight gain is a huge issue for many menopausal women